| Page 21 | Cafepharma

You are here

Primary tabs

aMoon Life Science Fund Closes on $660 Million

Post date: March 6, 2019 - 9:40am

Xenetic Biosciences to Acquire Personalized CAR T Platform

Post date: March 4, 2019 - 9:59am

Minimally-invasive Carotid Revascularization Company Files for $86 Million IPO

Post date: March 4, 2019 - 9:37am

Abpro and NJCTTQ Forge Development Partnership Worth Up to $4 Billion

Post date: March 1, 2019 - 9:48am

Microbiome Report for Week Ending 2/23/19

Post date: February 28, 2019 - 9:20pm

Evotec Receives Milestone Payment for Initiating Ph II Trials of Persistent Cough Drug

Post date: February 28, 2019 - 10:35am

Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Cardiovascular Disease Treatments

Post date: February 27, 2019 - 10:14am

Live Blog: Seven Pharma Execs Face Senate Finance Committee to Discuss Drug Pricing

Post date: February 26, 2019 - 10:20am

Xynomic Starts Ph III Trial of Abexinostat in Renal Cell Carcinoma

Post date: February 26, 2019 - 10:02am

FDA Accepts for Review Alkermes' and Biogen's NDA for Multiple Sclerosis Drug

Post date: February 25, 2019 - 10:16am

Pages